Description: What if you could treat more cardiometabolic patients, more effectively, in far fewer steps? Learn what’s possible with Abbott POCT products.
Discover Abbott Practice Solutions for your Cardiometabolic patient management
Chronic cardiometabolic diseases are surging worldwide. For example, there are now over 400 million cases of diabetes — and that number will rise by more than 50% in the next 25 years. 1 Although practice guidelines include testing for HbA1c, Lipids and ACR, fewer than 7% of patients are tested at the guideline recommended frequency and only 26.7% of patients are meeting targets for glycemic, blood pressure and cholesterol control. 2,3 New, more efficient methods for handling this growing epidemic are neede
Point-of care tests (POCT), such as rapid diagnostics from Abbott, have been shown to improve patient medical outcomes and practice efficiency. 4